← FDA Drug Approvals (Drugs@FDA)

ROPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-03-08

Drug application

FDA Application #

ANDA216605

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROPIVACAINE HYDROCHLORIDE

Generic name

ROPIVACAINE HYDROCHLORIDE

Active ingredients

ROPIVACAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2023-03-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown